Market capitalization | SEK20.90b |
Enterprise Value | SEK20.69b |
P/E (TTM) P/E ratio | 155.96 |
EV/FCF (TTM) EV/FCF | 322.45 |
EV/Sales (TTM) EV/Sales | 23.02 |
P/S ratio (TTM) P/S ratio | 23.26 |
P/B ratio (TTM) P/B ratio | 28.74 |
Revenue growth (TTM) Revenue growth | 52.05% |
Revenue (TTM) Revenue | SEK898.73m |
As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.
3 Analysts have issued a Bonesupport Holding AB forecast:
3 Analysts have issued a Bonesupport Holding AB forecast:
Dec '24 |
+/-
%
|
||
Revenue | 899 899 |
52%
52%
|
|
Gross Profit | 832 832 |
54%
54%
|
|
EBITDA | 154 154 |
394%
394%
|
EBIT (Operating Income) EBIT | 147 147 |
562%
562%
|
Net Profit | 134 134 |
45%
45%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.
Head office | Sweden |
CEO | Emil Billbäck |
Founded | 2010 |
Website | www.bonesupport.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.